据华尔街日报：美国食品药品监督管理局（FDA）重新调整药品审批流程，包括加快部分药物的审批速度以及增加人工智能的应用。

Core Insights - The FDA is revising its drug approval process to accelerate the approval speed of certain medications and increase the application of artificial intelligence [1] Group 1 - The FDA's adjustments aim to enhance the efficiency of drug approvals [1] - The incorporation of artificial intelligence is expected to streamline the evaluation process for new drugs [1]